How much revenue does OncoVista Innovative Therapies make?

OncoVista Innovative Therapies reported $0 in revenue for fiscal year 2014. In Q3 2015 revenue was $0.

What companies are similar to OncoVista Innovative Therapies?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Corix Bioscience, Inc. (CXBS), Neurobiological Technologies, Inc. (NTII), TetraLogic Pharmaceuticals Corporation (TLOG), Khiron Life Sciences Corp. (KHRNF).

OncoVista Innovative Therapies, Inc. (OVIT) Stock

About OncoVista Innovative Therapies, Inc.

OncoVista Innovative Therapies, Inc. does not have significant business. Previously, it engaged in development of targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas.

At a glance

OncoVista Innovative Therapies reported revenue of $0 for fiscal year 2014, and net income of -$2.54 million. In Q3 2015 (the quarter ended September 30, 2015) revenue was $0.

Figures from company filings; latest fiscal year ended December 31, 2014.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.